EMERGENT BIOSOLUT (ER4 BE) stock market data APIs
€7.1734
0(0%)
as of March 10, 2026
Try our APIs with
free plan!
EMERGENT BIOSOLUT Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ER4.BE.
Prev. Close
7.1734
Open
7.1734
High
7.1734
Low
7.1734
52 wk Range
3.77-11.11
Market Cap
1 908 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EMERGENT BIOSOLUT data using free add-ons & libraries
Get EMERGENT BIOSOLUT Fundamental Data
EMERGENT BIOSOLUT Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-26
- EPS/Forecast: 0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EMERGENT BIOSOLUT News
New
Emergent Biosolutions: Q4 Earnings Snapshot
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Thursday reported a loss of $54.6 million in its fourth quarter. On a per-share basis, the Gaithersburg, Mary...
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
Emergent BioSolutions Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 million Fourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37% Fu...
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness
Emergent BioSolutions WINNIPEG, Manitoba, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced a series of new contracts and a contract modification with the Public Hea...
NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading
Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its production of the Covid-19 vaccine. Continue Reading
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
